Zanubrutinib vs FCR in Fit Treatment-Naive Patients with Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

被引：0
|
作者：
Munir, Talha [1 ]
Mohseninejad, Leyla [2 ]
Xu, Sheng [3 ]
Jevdjevic, Milica [4 ]
Bouwmeester, Walter [4 ]
Yang, Keri [5 ]
机构：
[1] St James Univ Hosp, Dept Haematol, Leeds, W Yorkshire, England
[2] BeiGene Netherlands BV, Schiphol, Netherlands
[3] BeiGene Shanghai Co Ltd, Shanghai, Peoples R China
[4] PRECISIONheor, London, England
[5] BeiGene USA, San Mateo, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-173172
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Pirtobrutinib versus venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparison
    Al-Sawaf, Othman
    Jen, Min-Hua
    Hess, Lisa M.
    Zhang, Jiewen
    Goebel, Benjamin
    Pagel, John M.
    Abhyankar, Sarang
    Davids, Matthew S.
    Eyre, Toby A.
    HAEMATOLOGICA, 2024, 109 (06) : 1866 - 1873
  • [22] Matching-adjusted indirect comparison of nivolumab plus ipilimumab and BRAF plus MEK inhibitors for the treatment of BRAF-mutant treatment-naive advanced melanoma
    Atkins, Michael B.
    McDermott, David
    Tarhini, Ahmad
    Rael, Michael
    Gupte-Singh, Komal
    O'Brien, Elliot
    Ritchings, Corey
    Rao, Sumati
    CANCER RESEARCH, 2018, 78 (13)
  • [23] Zanubrutinib vs. bendamustine plus rituximab (BR) in patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma: extended follow-up of the SEQUOIA Study
    Brown, Jennifer
    Munir, Talha
    Shadman, Mazyar
    Robak, Tadeusz
    Kahl, Brad S.
    Ghia, Paolo
    Giannopoulos, Krzysztof
    Simkovic, Martin
    Osterborg, Anders
    Laurenti, Luca
    Walker, Patricia
    Opat, Stephen
    Ciepluch, Hanna
    Greil, Richard
    Hanna, Merit
    Tani, Monica
    Trneny, Marek
    Brander, Danielle
    Flinn, Ian
    Grosicki, Sebastian
    Verner, Emma
    Tedeschi, Alessandra
    De Guibert, Sophie
    Tumyan, Gayane
    Laribi, Kamel
    Garcia-Marco, Jose A.
    Li, Jianyong
    Tian, Tian
    Ramakrishnan, Vanitha
    Liu, Yu
    Szeto, Andy
    Paik, Jason
    Cohen, Aileen
    Tam, Constantine S.
    Jurczak, Wojciech
    LEUKEMIA & LYMPHOMA, 2023, 64 : S66 - S67
  • [24] Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis
    Strand, Vibeke
    McInnes, Iain
    Mease, Philip
    Nash, Peter
    Thom, Howard
    Kalyvas, Chrysostomos
    Hunger, Matthias
    Gandhi, Kunal
    Pricop, Luminita
    Jugl, Steffen
    Choy, Ernest
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (07) : 497 - 510
  • [25] MATCHING-ADJUSTED INDIRECT COMPARISON OF IXEKIZUMAB VS. TOFACITINIB IN PSORIATIC ARTHRITIS
    Sapin, C.
    Panni, T.
    Meszaros, G.
    Hill, J.
    Hartz, S.
    VALUE IN HEALTH, 2020, 23 : S593 - S593
  • [26] Disseminated Cryptococcal Infection in Treatment-Naive Patients With Chronic Lymphocytic Leukemia (CLL)
    Gujabidze, Kakha
    Hussain, Subaha Akram
    Balint, Stephanie
    Saadeh, Basel
    Yucelen, Sumeyra
    Shiferaw, Bethel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [27] Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naive Patients With Chronic Lymphocytic Leukemia: A Cross-Trial Comparison
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 2 - 3
  • [28] Matching-adjusted indirect treatment comparison of guselkumab and ixekizumab in patients with moderate-to-severe psoriasis
    Varu, Abhishek
    Cameron, Chris
    Diels, Joris
    Hutton, Brian
    McElligott, Sean
    Schubert, Agata
    van Sanden, Suzy
    Villacorta, Reggie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB187 - AB187
  • [29] Phase 3 zanubrutinib (BGB-3111) vs bendamustine plus rituximab (BR) in patients (pts) with treatment-naive (TN) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
    Hillmen, Peter
    Brown, Jennifer R.
    Kahl, Brad S.
    Ghia, Paolo
    Robak, Tadeusz
    Marimpietri, Carol
    Cohen, Aileen
    Huang, Jane
    Tam, Constantine Si Lun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Changes in immune cell numbers and profile during long-term zanubrutinib treatment in treatment-naive and relapsed/refractory patients with chronic lymphocytic leukemia
    Andersson, Maria
    Mulder, Tom
    Heimersson, Kia
    Sonnert-Husa, Sonja
    Giertz, Annika
    Karlsson, Claes
    Lundin, Jeanette
    Hansson, Lotta
    Osterborg, Anders
    Palma, Marzia
    LEUKEMIA & LYMPHOMA, 2023, 64 : S23 - S24
12345